OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19
Saskia Trump, Soeren Lukassen, Markus S. Anker, et al.
Nature Biotechnology (2020) Vol. 39, Iss. 6, pp. 705-716
Open Access | Times Cited: 156

Showing 1-25 of 156 citing articles:

Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children
Jennifer Loske, Jobst Röhmel, Soeren Lukassen, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 3, pp. 319-324
Open Access | Times Cited: 309

Hypertension
Meena S. Madhur, Fernando Elijovich, Matthew R. Alexander, et al.
Circulation Research (2021) Vol. 128, Iss. 7, pp. 908-933
Open Access | Times Cited: 156

Impact of the Human Cell Atlas on medicine
Jennifer Rood, Aidan Maartens, Anna Hupalowska, et al.
Nature Medicine (2022) Vol. 28, Iss. 12, pp. 2486-2496
Open Access | Times Cited: 145

Role of Hypertension on the Severity of COVID-19: A Review
Mei Peng, Jia He, Ying Xue, et al.
Journal of Cardiovascular Pharmacology (2021) Vol. 78, Iss. 5, pp. e648-e655
Open Access | Times Cited: 121

Hypertension and COVID-19: Current Evidence and Perspectives
Giovanna Gallo, Valentin Calvez, Carmine Savoia
High Blood Pressure & Cardiovascular Prevention (2022) Vol. 29, Iss. 2, pp. 115-123
Open Access | Times Cited: 111

Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19
Anna H.E. Roukens, Cilia R. Pothast, Marion König, et al.
Nature Immunology (2021) Vol. 23, Iss. 1, pp. 23-32
Open Access | Times Cited: 109

The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing
Chengdi Wang, Qiuxiao Yu, Tingting Song, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 109

Intensive care management of patients with COVID-19: a practical approach
Ludhmila Abrahão Hajjar, Isabela Bispo Santos da Silva Costa, Stéphanie Itala Rizk, et al.
Annals of Intensive Care (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 108

COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes
Banafsheh Bigdelou, Mohammad Reza Sepand, Sahar Najafikhoshnoo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 90

Immune and inflammatory mechanisms in hypertension
Tomasz J. Guzik, Ryszard Nosalski, Pasquale Maffia, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 6, pp. 396-416
Closed Access | Times Cited: 85

Age-specific nasal epithelial responses to SARS-CoV-2 infection
Maximillian Woodall, Ana-Maria Cujba, Kaylee B. Worlock, et al.
Nature Microbiology (2024) Vol. 9, Iss. 5, pp. 1293-1311
Open Access | Times Cited: 22

Pharmacological Improvement of Cystic Fibrosis Transmembrane Conductance Regulator Function Rescues Airway Epithelial Homeostasis and Host Defense in Children with Cystic Fibrosis
Jennifer Loske, Mirjam Völler, Soeren Lukassen, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 209, Iss. 11, pp. 1338-1350
Open Access | Times Cited: 18

Single-cell immunology of SARS-CoV-2 infection
Yuan Tian, Lindsay N. Carpp, Helen E. R. Miller, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 1, pp. 30-41
Open Access | Times Cited: 101

Epidemiological Impact of Myocarditis
Ainoosh Golpour, Dimitri Patriki, Paul Hanson, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 603-603
Open Access | Times Cited: 90

Arterial hypertension – Clinical trials update 2021
Hussam Al Ghorani, Felix Götzinger, Michael Böhm, et al.
Nutrition Metabolism and Cardiovascular Diseases (2021) Vol. 32, Iss. 1, pp. 21-31
Open Access | Times Cited: 83

Hypertension, a Moving Target in COVID-19
Carmine Savoia, Massimo Volpe, Reinhold Kreutz
Circulation Research (2021) Vol. 128, Iss. 7, pp. 1062-1079
Open Access | Times Cited: 80

Distinctive features of severe SARS-CoV-2 pneumonia
G. R. Scott Budinger, Alexander V. Misharin, Karen M. Ridge, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 14
Open Access | Times Cited: 71

Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry
Shiyou Zhu, Ying Liu, Zhuo Zhou, et al.
Science China Life Sciences (2021) Vol. 65, Iss. 4, pp. 701-717
Open Access | Times Cited: 59

The Prospective Effect of Allopurinol on the Oxidative Stress Index and Endothelial Dysfunction in Covid-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Marwa S. Al‐Niemi, et al.
Inflammation (2022) Vol. 45, Iss. 4, pp. 1651-1667
Open Access | Times Cited: 56

Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective
Wenyue Zheng, Erkang Tian, Zhen Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40

New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine
Hanli Xu, Shuye Lin, Ziyun Zhou, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 7, pp. 739-776
Open Access | Times Cited: 30

SARS-CoV-2 immunity and functional recovery of COVID-19 patients 1-year after infection
Yan Zhan, Yufang Zhu, Shanshan Wang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 46

Hypertension and its management in COVID-19 patients: The assorted view
Gaber El‐Saber Batiha, Abdulrahim Gari, Norhan Elshony, et al.
International Journal of Cardiology Cardiovascular Risk and Prevention (2021) Vol. 11, pp. 200121-200121
Open Access | Times Cited: 46

Pre-activated anti-viral innate immunity in the upper airways controls early SARS-CoV-2 infection in children
Jennifer Loske, Joachim Röhmel, Soeren Lukassen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 45

Page 1 - Next Page

Scroll to top